(XNAS) NASDAQ 100 1C - Overview
Etf: Technology, Consumer Discretionary, Communication Services, Healthcare
| Risk 5d forecast | |
|---|---|
| Volatility | 21.1% |
| Relative Tail Risk | 0.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.06 |
| Alpha | -5.69 |
| Character TTM | |
|---|---|
| Beta | 0.279 |
| Beta Downside | 0.478 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.72% |
| CAGR/Max DD | 0.88 |
Description: XNAS NASDAQ 100 1C December 25, 2025
The Xtrackers NASDAQ 100 UCITS ETF 1C (XETRA:XNAS) tracks the Morningstar US Large-Cap Growth Index (NR USD), delivering exposure to the 100 largest non-financial U.S. growth companies listed on the NASDAQ. It is domiciled in Germany, classified as a U.S. Large-Cap Growth Equity ETF, and trades under the ticker XNAS.
Key metrics (as of the latest reporting period) include a total expense ratio of 0.20 % and an average daily trading volume of roughly 1.2 million shares, indicating solid liquidity. The fund’s top sector allocations are technology (~48 %), consumer discretionary (~18 %), and health care (~12 %), reflecting the NASDAQ 100’s heavy weighting toward tech innovators. Recent U.S. macro-data-particularly the Fed’s stance on interest rates and the strength of corporate earnings-are primary drivers of the index’s performance.
For a deeper, data-driven view of how this ETF fits into a diversified growth strategy, you might explore the analytics platform ValueRay for up-to-date risk-adjusted return metrics and scenario analysis.
What is the price of XNAS shares?
Over the past week, the price has changed by -2.43%, over one month by -3.26%, over three months by -3.00% and over the past year by +1.45%.
Is XNAS a buy, sell or hold?
What are the forecasts/targets for the XNAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 57.1 | 16.8% |
XNAS Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 669.1m EUR (669.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 669.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 669.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.94% (E(669.1m)/V(669.1m) * Re(6.94%) + (debt-free company))
Discount Rate = 6.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)